Finally, novel antibody–drug conjugates with NAMPT inhibitors as payloads have suppressed tumor growth in xenograft models of breast cancer (HER2-expressing MDA-MB-453 cells) and leukemia (B7H3-expressing THP-1 cells) [66]. This evidence concerns the gene NAMPT and neoplasm.